Status:

UNKNOWN

Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease.

Lead Sponsor:

University of Calgary

Collaborating Sponsors:

Crohn's and Colitis Foundation

Conditions:

Crohn Disease

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Diet is a determinant of gut microbial diversity and composition and is recognized as a potential environmental trigger for IBD; for example, high-fat diets are associated with increased risk of CD in...

Detailed Description

Objectives: To determine if a 12-week IF intervention compared to SM: 1. Induces weight loss of at least 1 BMI unit. 2. Reduces intestinal and systemic inflammation. 3. Alters gut microbial community...

Eligibility Criteria

Inclusion

  • ≥ 18 to ≤ 75 years of age;
  • ileocolonic or colonic CD in clinical remission diagnosed through conventional definitions with a Harvey Bradshaw Index (HBI) \< 5 within 3 months of recruitment;
  • presence of inflammation using an FCP ≥ 250 µg/g or a CRP ≥ 5 mg/L;
  • stable dosing of biologic agents and/or immunomodulators and/or oral or rectal 5-ASA, and no changes to medical management (including corticosteroid exposure) for at least 3 months prior to recruitment
  • presence of overweight or obesity with BMI \> 25 and a PG-SGA of class A.

Exclusion

  • upper gastrointestinal involvement CD, fistulizing disease;
  • documented strictures based on sonographic findings or colonoscopy within the last year;
  • \> 1 small bowel resection;
  • colectomy;
  • presence of an ostomy;
  • antibiotic use in past 3-months;
  • pregnancy;
  • corticosteroids in the last 3 months.

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT05230160

Start Date

March 1 2022

End Date

June 30 2025

Last Update

February 8 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

TRW building, Foothills, University of Calgary

Calgary, Alberta, Canada, T2N 4Z6

Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease. | DecenTrialz